If you've been paying any attention along the way, you'd know that today is the first major step in the commercialization process. You seem to want step #3 to occur before step #1, so you'll constantly be disappointed in things with that outlook. Let's see CLIA get underway, announcement of positive data, and then the BP partner will come on board.

Also, there is absolutely no evidence of "big dilution" coming after the proxy as you fear. That's an interesting concern of yours since you previously posted "First of all, Amarantus is now in a much better position than a year ago, access to cash through LPC, Lympro is much more advanced, Eltoprazine etc." Save the "big dilution" garbage for the other message boards.